Hören Sie monatlich Experten, die Artikel aus JCO Precision Oncology besprechen, moderiert von Dr. Abdul Rafeh Naqash. Informieren Sie sich über Neuigkeiten in der Krebsbehandlung.
ctDNA as a Prognostic Biomarker in EGC
6 mins • Jan 29, 2025
Charts
- 191NEW
- 174Decreased by 22
- 145NEW
- 118Increased by 25
- 163Increased by 15
Neueste Folgen
![](https://files.podcastos.com/shows/whmd5w/jpeg256-ff5c95aa.jpg)
Jan 29, 2025
ctDNA as a Prognostic Biomarker in EGC
6 mins
![](https://files.podcastos.com/shows/whmd5w/jpeg256-ff5c95aa.jpg)
Jan 15, 2025
Proteomics Predictor for Immunotherapy Benefit
21 mins
![](https://files.podcastos.com/shows/whmd5w/jpeg256-ff5c95aa.jpg)
Dec 18, 2024
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
23 mins
![](https://files.podcastos.com/shows/whmd5w/jpeg256-ff5c95aa.jpg)
Nov 27, 2024
JCO Precision Oncology Article Insights: Germline Pathogenic Variants in Renal Cell Carcinoma
10 mins
![](https://files.podcastos.com/shows/whmd5w/jpeg256-ff5c95aa.jpg)
Nov 15, 2024
Uptake of Aspirin Chemoprevention in Lynch Syndrome
31 mins
![](https://files.podcastos.com/shows/whmd5w/jpeg-c1b0ebe2.jpg)
Sprache
Englisch
Land
Vereinigte Staaten
Feed Host
Website
Feed
Aktualisierung anfordern
Aktualisierungen können einige Minuten dauern.